D
DNLI//CIK 0001714899
Denali Therapeutics Inc.
Market Data
$20.85+$3.98 (+23.59%)
DNLI · Last trade
Prev Close
$16.87
Range (30d)
$16.02 – $21.25
Recent Filings
- 8-K242.7 KBDenali Therapeutics Inc.Jan 6, 8:02 AM ET·0001714899-26-000004
- 8-K813.9 KBDenali Therapeutics Inc.Dec 10, 5:21 PM ET·0001628280-25-056363
- 8-K20.0 MBDenali Therapeutics Inc.Dec 4, 7:01 AM ET·0001714899-25-000209
- 8-K274.1 KBDenali Therapeutics Inc.Dec 4, 7:01 AM ET·0001714899-25-000208
- 10-Q6.4 MBDenali Therapeutics Inc.Nov 6, 4:05 PM ET·0001714899-25-000193
- 8-K1.1 MBDenali Therapeutics Inc.Nov 6, 4:03 PM ET·0001714899-25-000192
- 8-K184.1 KBDenali Therapeutics Inc.Oct 14, 8:10 AM ET·0001714899-25-000180
- 10-Q6.4 MBDenali Therapeutics Inc.Aug 11, 4:25 PM ET·0001714899-25-000170
- 8-K1.1 MBDenali Therapeutics Inc.Aug 11, 4:03 PM ET·0001714899-25-000167
- 8-K191.4 KBDenali Therapeutics Inc.Jul 7, 8:04 AM ET·0001714899-25-000146
Insiders
10- 667, L.P.Director
- AFEYAN NOUBAR10% Owner
- ARCH Venture Fund VIII, L.P.10% Owner
- ARCH Venture Partners VIII, LLC10% Owner
- ARCH Venture Partners VIII, L.P.10% Owner
- Baker Bros. Advisors (GP) LLCDirector
- BAKER BROS. ADVISORS LPDirector
- Baker Brothers Life Sciences LPDirector
- BAKER FELIXDirector
- BAKER JULIANDirector
Tickers
Addresses
business
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080
mailing
161 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO, CA, 94080